{
  "request": {
    "url": "https://query2.finance.yahoo.com/v10/finance/quoteSummary/ABBV?formatted=false&modules=summaryProfile"
  },
  "response": {
    "ok": true,
    "status": 200,
    "statusText": "OK",
    "headers": {
      "x-yahoo-request-id": [
        "anunar1g6s9a6"
      ],
      "cache-control": [
        "max-age=1, stale-while-revalidate=15, stale-if-error=3600"
      ],
      "content-encoding": [
        "gzip"
      ],
      "content-type": [
        "application/json;charset=utf-8"
      ],
      "vary": [
        "Origin"
      ],
      "content-length": [
        "1315"
      ],
      "date": [
        "Wed, 07 Apr 2021 21:33:58 GMT"
      ],
      "age": [
        "0"
      ],
      "server": [
        "ATS"
      ],
      "x-frame-options": [
        "SAMEORIGIN"
      ],
      "referrer-policy": [
        "no-referrer-when-downgrade"
      ],
      "strict-transport-security": [
        "max-age=15552000"
      ],
      "connection": [
        "close"
      ],
      "expect-ct": [
        "max-age=31536000, report-uri=\"http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only\""
      ],
      "x-xss-protection": [
        "1; mode=block"
      ],
      "x-content-type-options": [
        "nosniff"
      ]
    },
    "bodyJson": {
      "quoteSummary": {
        "result": [
          {
            "summaryProfile": {
              "address1": "1 North Waukegan Road",
              "city": "North Chicago",
              "state": "IL",
              "zip": "60064-6400",
              "country": "United States",
              "phone": "847 932 7900",
              "website": "http://www.abbvie.com",
              "industry": "Drug Manufacturers—General",
              "sector": "Healthcare",
              "longBusinessSummary": "AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal BehÃ§et's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrÃ¶m's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production. The company was incorporated in 2012 and is based in North Chicago, Illinois.",
              "fullTimeEmployees": 47000,
              "companyOfficers": [],
              "maxAge": 86400
            }
          }
        ],
        "error": null
      }
    }
  }
}